[1] |
GREER J P,ARBER D A,GLADER B,et al.Wintrobe's clinical hematology[M]. 13th ed. Philadelphia:Lippincott Williams & Wilkins,2013.
|
[2] |
胡文静,叶盛,费荣,等. 血液病患者预防性血小板输注的研究进展[J]. 临床血液学杂志,2016,29(1):86-88.
|
[3] |
KAUFMAN R M,DJULBEGOVIC B,GERNSHEIMER T,et al.Platelet transfusion:a clinical practice guideline from the AABB[J]. Ann Intern Med,2015,162(3):205-213.
|
[4] |
BRIGGS C,HART D,KUNKA S,et al.Immature platelet fraction measurement:a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation[J]. Transfus Med,2006,16(2):101-109.
|
[5] |
MICHUR H,MALANKA K,SZCZEPISKI A,et al.Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation[J]. Int J Lab Hematol,2008,30(6):519-525.
|
[6] |
TAKAMI A,SHIBAYAMA M,ORITO M,et al.Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation[J]. Bone Marrow Transplant,2007,39(8):501-507.
|
[7] |
MARTINELLI G,MERLO P,FANTASIA R,et al.Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation[J]. Transfus Apher Sci,2009,40(3):175-181.
|
[8] |
YAMAOKA G,KUBOTA Y,NOMURA T,et al.The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation[J]. Int J Lab Hematol,2010,32(6 Pt 1):e208-e216.
|
[9] |
GONÇALO A P,BARBOSA I L,CAMPILHO F,et al.Predictive value of immature reticulocyte and platelet fractions in hematopoietic recovery of allograft patients[J]. Transplant Proc,2011,43(1):241-243.
|
[10] |
KIENAST J,SCHMITZ G.Flow cytometric analysis of thiazole orange uptake by platelets:a diagnostic aid in the evaluation of thrombocytopenic disorders[J]. Blood,1990,75(1):116-121.
|
[11] |
RICHARDS E M,BAGLIN T P.Quantitation of reticulated platelets:methodology and clinical application[J]. Br J Haematol,1995,91(2):445-451.
|
[12] |
BARSAM S J,PSAILA B,FORESTIER M,et al.Platelet production and platelet destruction:assessing mechanisms of treatment effect in immune thrombocytopenia[J]. Blood,2011,117(21):5723-5732.
|
[13] |
KURATA Y,HAYASHI S,KIYOI T,et al.Diagnostic value of tests for reticulated platelets,plasma glycocalicin,and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia[J]. Am J Clin Pathol,2001,115(5):656-664.
|
[14] |
KUWANA M,KURATA Y,FUJIMURA K,et al.Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura:evaluation by multi-center prospective study[J]. J Thromb Haemost,2006,4(9):1936-1943.
|
[15] |
林孝怡,陈骊婷,沈韻. Sysmex XN血液分析仪未成熟血小板比率在血小板减少性疾病中的应用[J]. 检验医学,2019,34(2):159-161.
|
[16] |
SAKURAGI M,HAYASHI S,MARUYAMA M,et al. Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders[J]. Int J Hematol,2015,101(4):369-375.
|
[17] |
夏永辉,李筱梅,李勇,等. IPF相关参数参考范围调查及其在血小板减少性疾病诊断中的探讨[J]. 检验医学,2012,27(9):745-748.
|
[18] |
SAKURAGI M,HAYASHI S,MARUYAMA M,et al.Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation[J]. Int J Hematol,2018,107(3):320-326.
|